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A Rare Cause of Cardiac Tamponade: Hypereosinophilic Syndrome
KWOK-LEUNG WU, KIN-LAM TSUI, KA-LAI LEE, SUNG-YU LIU, KWOK-KEUNG CHAN, SHU-KIN LI
From Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong
WU ET AL.: A Rare Cause of Cardiac Tamponade: Hypereosinophilic Syndrome. We describe a male adult
patient who presented with chest discomfort and shortness of breath. A diagnosis of cardiac tamponade was made by
transthoracic echocardiogram. Urgent pericardiocentesis was performed and analysis of pericardial fluid showed
presence of eosinophil. Complete blood picture showed peripheral eosinphilia as well. Subsequent work up for
eosinophilia showed ova of Clonorchis sinesis from the stool thus a course of praziquantel was given. Transient
clinical improvement and lowering of eosinophil count were observed but two weeks later he developed acute coronary
syndrome. Urgent coronary angiogram showed coronary vasospasm. Endomyocardial biopsy was performed afterwards
which showed marked eosinophilic infiltrate. Bone marrow biopsy and skin biopsy showed marked marrow eosinophilia
and leucocytoclastic vasculitis with abundant eosinophils, respectively. A diagnosis of hypereosinophilic syndrome
was made after exclusion of secondary and clonal eosinophilia. After oral steroid was given, his condition was
stabilized and the eosinophil count was normalized. (J HK Coll Cardiol 2012;20:38-42)
Cardiac tamponade, Hypereosinophilic syndrome, perimyocarditis, prednisolone, vasospasm

Introduction
Hypereosinophilic syndrome (HES) is a rare
entity characterized by overproduction of eosinophils
resulting in end-organ damage. We report a case of HES
presented with cardiac tamponade, impaired left

ventricular systolic function and acute coronary
syndrome due to vasospasm. The case illustrates the
diagnostic and treatment approach to this condition. It
also illustrates the dilemma in management when
the patient was also diagnosed to have coexisting
Clonorchiasis as an alternative cause of eosinophilia.
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A 51-year-old gentleman, who had history of
asthma, presented with chest pain for 2 days. On arrival
to the casualty department his blood pressure was
75/50 mmHg, pulse 120 bpm, and the oxygen saturation

October 2012

J HK Coll Cardiol, Vol 20

WU ET AL.

was 97% while on 4 Litre oxygen. Electrocardiogram
(Figure 1) showed sinus tachycardia 112 bpm. Chest
X-Ray showed cardiomegaly. Dopamine infusion was
given. Blood result showed total white cell count
13.1x109/L, neutrophil count 4.6x109/L, lymphocyte count
1.5x109/L and eosinophil count 6.2x109/L (47.6% of total
white cell count). Echocardiogram demonstrated mildly
depressed left ventricular systolic function with left
ventricular ejection fraction around 40%, and pericardial
effusion with signs of cardiac tamponade. Urgent
pericardiocentesis was performed. The chest pain
subsided and the hemodynamic status was stabilized
afterwards.
Echocardiogram was repeated on the next day
which showed moderately impaired left ventricular
systolic function and the left ventricular ejection fraction
measured around 40%. Mild tricuspid regurgitation was
noted. No pericardial effusion was detected. Analysis
of pericardial fluid revealed presence of eosinophil. A
review of the patient's previous admission record
showed that his eosinophil count was already raised
(3.7x109/L) seven months before this admission, when
he was admitted for an asthmatic attack. Further workup
for eosinophilia was performed, which included
checking of autoimmune markers (including antineutrophil cytoplasmic antibody) and tumor markers.

All these results were negative. Stool was saved for
parasites. Nerve conduction study was performed
because he complaint of occasional numbness over
bilateral lower limbs, which showed no evidence of
vasculitic polyneuropathy. High resolution computer
tomography of thorax showed only non-specific ground
glass densities. Subsequently the stool culture yielded
ova of Clonorchis sinesis. A course of oral praziquantel
was given. Empirical steroid therapy was not started
because of proven parasitic infection. Before discharge
his eosinophil count was slightly lowered from 6.2
to 5.1x109/L (46.7% of total white cell count).
Two weeks later this gentlemen presented to
the casualty department again for chest pain.
Electrocardiogram showed ST segment depression over
the chest leads V4-6. Serum troponin level was elevated
up to 0.16 ng/dL. Total white cell count was 16.9x109/L
and eosinophil count was 8.3x10 9 /L (49.1%). A
diagnosis of acute coronary syndrome was made. Urgent
coronary angiogram (Figure 2) revealed coronary
vasospasm over the posterolateral artery and right
posterior descending artery, which was relieved by
intracoronary nitrate and verapamil injection.
Endomyocardial biopsy was performed several
days later in view of persistent peripheral eosinophilia,
which showed myocarditis associated with marked

Figure 1. Echocardiographic finding of pericardial effusion.
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eosinophilic infiltrate. Bone marrow aspiration and
trephine biopsy demonstrated marked marrow
eosinophilia. During admission this patient was noted
to have patchy erythematous rash with sharp
demarcation over bilateral lower limbs. Skin biopsy
showed leucocytoclastic vasculitis with marked
eosinophilic infiltrate. Stool culture was repeated which
showed no growth. The diagnosis of hypereosinophilic
syndrome was made. Blood for RT-PCR FIP1L1PDGRFα fusion (reverse transcription polymerase chain
reaction for the fusion of Fip1-like gene and plateletderived growth factor receptor alpha) was checked
which was negative.
Oral prednisolone 60 mg per day was then given.
The eosinophil count was normalized after several days.
Cardiac magnetic resonance imaging (MRI) was
performed before discharge which revealed moderately
impaired left ventricular systolic function (left
ventricular ejection fraction was 36.1%). There was also
diffuse scarring in the ventricular wall which suggested
cardiac involvement in HES. During follow up he
remained asymptomatic and the eosinophil count
remained normal. Oral prednisolone was tailed down
to 5 mg daily and the plan was to keep this dosage for
longer period of time. Follow up cardiac MRI at 4

months after discharge showed improvement in left
ventricular systolic function and moderate resolution
of myocardial scarring.

Discussion
This patient presented with cardiac tamponade,
impaired left ventricular systolic function and acute
coronary syndrome due to coronary vasospasm. All
these features could be explained by acute eosinophilic
myocarditis which was proven by endomyocardial
biopsy. Peripheral eosinophilia was noted and several
end organs were involved. Eosinophilia can be
categorized into secondary (caused by parasitic
infestations, vasculitis, drug and lymphoma), clonal
(presence of histological, cytogenetic, or molecular
evidence of underlying myeloid malignancy) an
idiopathic (such as HES) types.1 It is essential to identify
the type of eosinophilia because subsequent
management may be very different. Hypereosinophilic
syndrome, a subcategory of idiopathic eosinophilia, is
defined by the presence of a peripheral blood eosinophil
count of 1.5x109/L or greater for at least 6 months,
exclusion of both secondary and clonal eosinophilia and

Figure 2. Coronary angiogram showed coronary vasospasm over the posterolateral artery and right posterior descending artery
(left panel), which was relieved by intracoronary nitrate and verapamil injection (right panel).
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evidence of end organ involvement.
In this case a secondary cause for eosinophilia
was present, which was infestation by Clonorchiasis.
This posed diagnostic and treatment dilemma and
rendered steroid therapy inappropriate in the initial
status. However, as HES carries high morbidity
and mortality, treatment by systemic steroid or
immunosuppressive agents should be initiated once the
infestation was cleared. In this case despite initiation of
praziquantel, the patient developed recurrent symptom
with rebound of the eosinophil count. During the second
admission stool culture was negative. In fact peripheral
eosinophilia in Clonorchiasis seldom exceeds 10 to 20%
and the infestation is primarily, if not exclusively,
confined to the hepatobiliary system. The eosinophil
count was around 40% of total white cell count in this
case. Multi-organ involvement was proven by
histological analysis. This implied that infestation by
Clonorchiasis was only a clinical bystander in this case.
Apart from the bronchodilators and the inhaled
corticosteroid, this patient did not take other
medications. Hematological malignancy was excluded
by the bone marrow examination. Another important
differential diagnosis in this case was vasculitis,
especially Churg-Strauss syndrome (CSS). This case did
not completely fulfill the classification criteria of CSS,
because it only fitted into 3 (1st, 2nd and 5th ) out of 6
criteria by the American College of Rheumatology (need
to fulfill 4 out of 6 criteria): 1) Asthma; 2) Eosinophil
>10%; 3) Mono/polyneuropathy; 4) Paranasal sinus
pathology; 5) Histological proof of eosinophils in
extracellular space; 6) Migratory pulmonary opacities.2
On the other hand, anti-neutrophil cytoplasmic antibody
(ANCA) was negative in this case which render the
diagnosis of CSS less likely.
This patient had a peripheral blood eosinophil
count greater than 1.5x109/L for longer than 6 months.
There was evidence of multi-organ involvement as well,
manifested as acute eosinophilic myocarditis,
eosinophilic bone marrow infiltrate and leucocytoclastic
vasculitis. Secondary and clonal eosinophilia were less
likely in this case. Therefore the most likely diagnosis
was HES.
Cardiac involvement is a major cause of
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morbidity and mortality among patients with HES.3
Cardiac involvement usually presented as intra-cardiac
thrombus formation and endomyocardial fibrosis
causing restrictive cardiomyopathy. Cardiac magnetic
resonance imaging (MRI) and echocardiography are
able to detect fibrosis, eosinophilic infiltrate and thrombi
to stage the fibrotic evolution of the disease. Treatment
for heart failure, anticoagulation, immunosuppressive
therapy are the mainstay of management. The 5-year
mortality is estimated to be 30%.4 Loeffler's endocarditis
is a separate entity from HES.5 However, effects of
eosinophils on the heart may go through different stages
of initial necrotic phase with intense myocarditis, and
associated arteritis (Loeffler's endocarditis) followed by
thrombotic stage and finally endomyocardial fibrosis.
Pericardial involvement as in this case, is rare in
HES. In retrospect, pericardial or endomyocardial
biopsy should be considered during the initial
presentation, in order to start timely therapy. Spiegel
et al6 reported a case of eosinophilic pericarditis of an
18-month-old child who presented with eosinophilic
pericarditis causing cardiac tamponade requiring
pericardiocentesis. The child recovered after prolonged
systemic steroid therapy. Tan and Duggal7 also reported
a case with similar scenario in a 56-year-old female.
Although coronary vasospasm could occur in HES, in
this case the ST change and modest rise in troponin
could be accounted by eosinophilic cardiomyopathy
alone, and coronary vasospasm was only a laboratory
phenomenon. It was because one should expect ST
elevation in case of coronary vasospasm, instead of ST
depression in this case. Takahashi et al reported a case
of acute myocardial infarction in a young man with
history of HES. Coronary angiogram was performed
which showed vasospasm over the left anterior
descending artery. 8 The mechanism by which
eosinophils induce coronary spasm could be related
to massive infiltration of eosinophils into
endomyocardium and the deposition of their granular
proteins (such as eosinophilic cationic protein) which
may increase vascular tone or irritability.9
Bone marrow biopsy is important to exclude
secondary eosinophilia due to lymphoma, clonal
eosinophilia and the malignant variants of HES, the
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myeloproliferative variants and lymphocytic variants.10
Peripheral blood test for RT-PCR FIP1L1-PDGRFα
fusion was negative in our patient. A proportion of
patients with HES have an interstitial deletion on
chromosome 4q12 resulting in the fusion of two genes,
FIP1L1 and PDGFRα. Its presence indicates higher
likelihood of potentially fatal cardiac involvement.
Moreover, this group of patients will have response to
imatinib, a tyrosine kinase inhibitor.11 In such case
imatinib instead of steroid therapy should be started as
soon as possible to avoid rapid disease progression.
During follow up, features of end organ
involvement, thromboembolism and side effects arising
from steroid therapy should be looked for, and
eosinophil count should be monitored. Follow up
echocardiography and cardiac MRI are recommended
as well. For those on imatinib therapy, regular
monitoring of left ventricular systolic function is
necessary because it is known to cause left ventricular
systolic dysfunction.12

Conclusion
In summary, we reported a case of
hypereosinophilic syndrome with multiple cardiac
involvements. Apart from urgent pericardiocentesis to
relieve cardiac tamponade, recognition of this rare
disease entity, exclusion of secondary and clonal
eosinophilia, and appropriate steroid therapy is essential
for management of this potentially life-threatening
condition.
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